C-KAD

C-KAD is a chemical solution, composition not published, that allegedly breaks up the molecules which cause cataracts and may also treat the symptoms of glaucoma and macular degeneration. It was developed by Rajiv Bhushan an electrical engineer. There is no reference to C-KAD in the published medical literature.

It is entering the final stages of clinical testing and could be commercially available in 2010, [cite web
url=http://www.popsci.com/scitech/article/2008-04/no-more-blind-spots
title=No More Blind Spots | Popular Science
accessdate=2008-04-06
format=
work=popsci.com] which would make it the first non-surgical treatment for cataracts. Although C-KAD is not FDA approved it is available in the U.S. for a low price to treat eye irritation and dryness with N-Acetyl Carnosine listed as a non-active ingredient.cite web |url=http://www.bestsyndication.com/?q=20080312_cataract_eye_drops_can-c_C-KAD_macular_degeneration.htm |title=Can Eye Drops Cure Cataracts And Macular Degeneration? C-KAD OS And CAN-C Drops In Trials And On Market – Acetylcarnosine | Best Syndication |format= |work= |accessdate=]

References